Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine
Authors
Keywords
Metabotropic glutamate mGlu5 receptor, NMDA receptor, Social novelty discrimination, Adolescence, Development
Journal
PSYCHOPHARMACOLOGY
Volume 225, Issue 3, Pages 579-594
Publisher
Springer Nature
Online
2012-09-15
DOI
10.1007/s00213-012-2845-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
- (2012) Asha L. Bhakar et al. Annual Review of Neuroscience
- Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice
- (2012) Mao Horio et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function
- (2012) Hyejung Won et al. NATURE
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
- (2012) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Synaptic Dysfunction in Neurodevelopmental Disorders Associated with Autism and Intellectual Disabilities
- (2012) H. Y. Zoghbi et al. Cold Spring Harbor Perspectives in Biology
- Deficits in social cognition: a marker for psychiatric disorders?
- (2011) Birgit Derntl et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders
- (2011) Richard M. Cleva et al. MOLECULES
- Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex
- (2011) David JG Watson et al. NEUROPSYCHOPHARMACOLOGY
- Group II Metabotropic Glutamate Receptor Agonist Ameliorates MK801-Induced Dysfunction of NMDA Receptors via the Akt/GSK-3β Pathway in Adult Rat Prefrontal Cortex
- (2011) Dong Xi et al. NEUROPSYCHOPHARMACOLOGY
- Negative Symptoms and Social Cognition: Identifying Targets for Psychological Interventions
- (2011) T. M. Lincoln et al. SCHIZOPHRENIA BULLETIN
- Cognitive neuroscience of self-regulation failure
- (2011) Todd F. Heatherton et al. TRENDS IN COGNITIVE SCIENCES
- What does the amygdala contribute to social cognition?
- (2010) Ralph Adolphs Annals of the New York Academy of Sciences
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
- (2010) Colleen M. Niswender et al. Annual Review of Pharmacology and Toxicology
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Disruption of Performance in the Five-Choice Serial Reaction Time Task Induced By Administration of N-Methyl-D-Aspartate Receptor Antagonists: Relevance to Cognitive Dysfunction in Schizophrenia
- (2010) Nurith Amitai et al. BIOLOGICAL PSYCHIATRY
- Neonatal exposure to MK-801, an N-methyl-d-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats
- (2010) Takashi Uehara et al. BRAIN RESEARCH
- The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801
- (2010) Karel Vales et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator
- (2010) Holger Rosenbrock et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metabotropic glutamate receptor subtype 5 antagonism in learning and memory
- (2010) Agnes Simonyi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade
- (2010) Mark R. Stefani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats
- (2010) S.W. Fowler et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Metabotropic glutamate receptors: From the workbench to the bedside
- (2010) F. Nicoletti et al. NEUROPHARMACOLOGY
- Mechanism-based approaches to treating fragile X
- (2010) Gül Dölen et al. PHARMACOLOGY & THERAPEUTICS
- MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?
- (2010) Joshua D. Vardigan et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Homer1a-Dependent Crosstalk Between NMDA and Metabotropic Glutamate Receptors in Mouse Neurons
- (2010) Federica Bertaso et al. PLoS One
- Risperidone Administered During Asymptomatic Period of Adolescence Prevents the Emergence of Brain Structural Pathology and Behavioral Abnormalities in an Animal Model of Schizophrenia
- (2010) Y. Piontkewitz et al. SCHIZOPHRENIA BULLETIN
- Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats—A possible model for schizophrenia
- (2009) Paul Christian Baier et al. BEHAVIOURAL BRAIN RESEARCH
- Neonatal Phencyclidine Treatment in Mice Induces Behavioral, Histological and Neurochemical Abnormalities in Adulthood
- (2009) Akiko Nakatani-Pawlak et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Clozapine Administration in Adolescence Prevents Postpubertal Emergence of Brain Structural Pathology in an Animal Model of Schizophrenia
- (2009) Yael Piontkewitz et al. BIOLOGICAL PSYCHIATRY
- U-Shaped Dose Response in Behavioral Pharmacology: Historical Foundations
- (2009) Edward J. Calabrese CRITICAL REVIEWS IN TOXICOLOGY
- Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade
- (2009) Teresa Marie du Bois et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
- (2009) Yechiel Levkovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus
- (2009) Jason M. Uslaner et al. NEUROPHARMACOLOGY
- mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning
- (2009) Jennifer E Ayala et al. NEUROPSYCHOPHARMACOLOGY
- Activation of group I metabotropic glutamate receptors leads to brain-derived neurotrophic factor expression in rat C6 cells
- (2009) Kittikun Viwatpinyo et al. NEUROSCIENCE LETTERS
- Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia
- (2009) Chantal Schlumberger et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis
- (2009) Urs Meyer et al. PSYCHOPHARMACOLOGY
- MGlu5 antagonism impairs exploration and memory of spatial and non-spatial stimuli in rats
- (2008) Gert R.J. Christoffersen et al. BEHAVIOURAL BRAIN RESEARCH
- Effect of an NCAM mimetic peptide FGL on impairment in spatial learning and memory after neonatal phencyclidine treatment in rats
- (2008) Thomas Secher et al. BEHAVIOURAL BRAIN RESEARCH
- Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm
- (2008) Justin M. Darrah et al. BEHAVIOURAL PHARMACOLOGY
- Metabotropic glutamate receptor 1 (mGluR1) and 5 (mGluR5) regulate late phases of LTP and LTD in the hippocampal CA1 region in vitro
- (2008) Sergey Neyman et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity
- (2008) Kimberly R. Byrnes et al. GLIA
- ADX47273 [S-(4-Fluoro-phenyl)- -methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities
- (2008) F. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia☆
- (2008) D BOULAY et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice
- (2008) Ming-Huan Chan et al. PSYCHOPHARMACOLOGY
- Metabotropic Glutamate Receptors and Fragile X Mental Retardation Protein: Partners in Translational Regulation at the Synapse
- (2008) J. A. Ronesi et al. Science Signaling
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation